Mimetas
Mimetas develops and provides Organ-on-a-Chip technology, specifically the OrganoPlate platform, to create 3D human tissue models that replicate complex disease biology. The company offers products like OrganoReady and OrganoTEER, alongside CRO services and AI-powered analytics, to support pharmaceutical companies in drug discovery, safety testing, and efficacy assessment. Its models cover various therapeutic areas including oncology, immunology, and metabolic diseases, aiming to provide more predictive data than traditional animal experiments.
Biotechnology
Life Sciences
Pharmaceuticals
Healthtech
Funding summary
- Total raised
- €23.8M
- Funding rounds
- 3
Investors in Mimetas
Investors on record for Mimetas. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Mimetas?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors